β-Pinene alleviates arsenic (As)-induced oxidative stress by modulating enzymatic antioxidant activities in roots of Oryza sativa.

Autor: Kaur S; Department of Botany, Panjab University, Chandigarh 160014, India., Chowhan N; Department of Botany, Panjab University, Chandigarh 160014, India., Sharma P; Department of Environment Studies, Panjab University, Chandigarh 160014, India., Rathee S; Department of Botany, Panjab University, Chandigarh 160014, India., Singh HP; Department of Environment Studies, Panjab University, Chandigarh 160014, India. Electronic address: hpsingh_01@yahoo.com., Batish DR; Department of Botany, Panjab University, Chandigarh 160014, India. Electronic address: daizybatish@pu.ac.in.

Publikováno v: Ecotoxicology and environmental safety [Ecotoxicol Environ Saf] 2022 Jan 01; Vol. 229, pp. 113080. Date of Electronic Publication: 2021 Dec 17.

Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial.

Autor: Yang JC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, Republic of China. Electronic address: chihyang@ntu.edu.tw., Camidge DR; Department of Medicine Division of Medical Oncology, University of Colorado Health, Aurora, Colorado., Yang CT; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan, Republic of China., Zhou J; Department of Respiratory Medicine, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China., Guo R; Department of Medical Oncology, Jiangsu Province Hospital, Nanjing, Jiangsu, People's Republic of China., Chiu CH; Division of Thoracic Oncology, Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China., Chang GC; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China., Shiah HS; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan, Republic of China., Chen Y; Department of Oncology, Tongji Medical College of HUST, Wuhan, Hubei, China., Wang CC; Department of Occupational Medicine, Chang Gung Memorial Hospital- Kaohsiung, Kaohsiung, Taiwan, Republic of China., Berz D; Department of Cellular Therapeutics, Beverly Hills Cancer Center, Beverly Hills, California., Su WC; Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China., Yang N; Department of Medical Oncology, Hunan Cancer Hospital, Changsha, Hunan, China., Wang Z; Department of Chest Medicine, Beijing Cancer Hospital, Beijing, China., Fang J; Department of Chest Medicine, Beijing Cancer Hospital, Beijing, China., Chen J; Department of Medical Oncology, Hunan Cancer Hospital, Changsha, Hunan, China., Nikolinakos P; Department of Research, University Cancer & Blood Center, LLC, Athens, Georgia., Lu Y; Department of Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan, China., Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China., Maniam A; Division of Hematology and Oncology, Pacific Cancer Medical Center Inc., Anaheim, California., Bazhenova L; Department of Medicine, Moores Cancer Center, University of California San Diego Health, La Jolla, California., Shirai K; Department of Hematology and Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Jahanzeb M; Department of Clinical Medicine, Hematology-Oncology, Sylvester Comprehensive Cancer Center, Miami, Florida., Willis M; Department of Oncology, University of Texas Medical Branch at Galveston, Galveston, Texas., Masood N; Department of Medical Oncology, MultiCare Regional Cancer Center, MultiCare Institute for Research and Innovation, Tacoma, Washington., Chowhan N; Department of Research, Baptist Healthcare Systems Inc., Baptist Health Floyd, New Albany, Indiana., Hsia TC; Division of Pulmonary and Critical Care Medicine, China Medical University Hospital, Taichung, Taiwan, Republic of China., Jian H; Department of Oncology, Shanghai Chest Hospital, Shanghai, People's Republic of China., Lu S; Department of Oncology, Shanghai Chest Hospital, Shanghai, People's Republic of China.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2020 Dec; Vol. 15 (12), pp. 1907-1918. Date of Electronic Publication: 2020 Sep 09.

P1.01-62 The Third Generation Irreversible EGFR Inhibitor HS-10296 in Advanced Non-Small Cell Lung Cancer Patients

Autor: Lu, S., Camidge, R., Yang, C., Zhou, J., Guo, R., Chiu, C., Chang, G., Shiah, H., Chen, Y., Wang, C., Berz, D., Su, W., Yang, N., Wang, Z., Fang, J., Chen, J., Nikolinakos, P., Lu, Y., Pan, H., Maniam, A., Bazhenova, L., Shirai, K., Jahanzeb, M., Willis, M., Masood, N., Chowhan, N., Hsia, T., Yang, J.C.

Publikováno v: In Journal of Thoracic Oncology October 2018 13(10) Supplement:S485-S485

Biological activity of the essential oil of Drimys winteri.

Autor: Navarro, Myriam^1,2, Urrejola, Felipe², Espinoza, Misael², Silva, Simón², González, Sebastián², Utreras, Diego², Fernandez, Katia^1,2, Bravo, Jessica² jessica.bravo@udp.cl

Publikováno v: Frontiers in Chemistry. 2024, p1-7. 7p.

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. oncology.

Autor: Hanna N, Neubauer M, Yiannoutsos C, McGarry R, Arseneau J, Ansari R, Reynolds C, Govindan R, Melnyk A, Fisher W, Richards D, Bruetman D, Anderson T, Chowhan N, Nattam S, Mantravadi P, Johnson C, Breen T, White A, Einhorn L

Publikováno v: Journal of Clinical Oncology; 12/10/2008, Vol. 26 Issue 35, p5755-5760, 6p